Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-24T13:17:56.316Z Has data issue: false hasContentIssue false

Benzodiazepine-Induced and Anticholinergic-Induced Delirium in the Elderly

Published online by Cambridge University Press:  07 January 2005

Larry E. Tune
Affiliation:
Department of Psychiatry and Behavioral Sciences, The John Hopkins School of Medicine, Baltimore, Maryland, U.S.A.
Fred W. Bylsma
Affiliation:
Department of Psychiatry and Behavioral Sciences, The John Hopkins School of Medicine, Baltimore, Maryland, U.S.A.

Abstract

Encompassing the range from subtle cognitive impairments to frank delirium, toxicity due to benzodiazepines and to anticholinergic-containing compounds is reviewed. For benzodiazepines, an extensive literature suggests that they impair immediate and delayed memory, psychomotor performance, and subjective complaints of station. This, in several studies, results in increased patient morbidity (e.g., increasing risk of hip fractures). Anticholinergic compounds are widely utilized in managing elderly patients, particularly nursing home residents. Toxicity from anticholinergic compounds, detected by anticholinergic drug levels, is significantly correlated with the presence and severity of delirium in a number of settings including postoperative patients and elderly nursing home residents. Possible means of identifying the syndrome by prediction of dose and type of medication, as well as by quantitative EEG, are reviewed.

Type
Etiological Models and their Phenomenological Variants: Toxicity Models
Copyright
© 1991 Springer Publishing Company

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)